ATHE

Alterity Therapeutics Ltd

Company with tickers: ATHE, PRNAF

CIK
1131343
CUSIP
02155X205
Shares Outstanding
18,125,694
Line Item Value
Revenue
Revenue (ASC 606)
Cost of Revenue
Gross Profit
Operating Expenses
Research & Development
Operating Income
Net Income
EPS (Basic)
EPS (Diluted)